These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38043981)

  • 21. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.
    Meneghini V; Lattanzi A; Tiradani L; Bravo G; Morena F; Sanvito F; Calabria A; Bringas J; Fisher-Perkins JM; Dufour JP; Baker KC; Doglioni C; Montini E; Bunnell BA; Bankiewicz K; Martino S; Naldini L; Gritti A
    EMBO Mol Med; 2016 May; 8(5):489-510. PubMed ID: 27025653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
    Parambi DGT; Alharbi KS; Kumar R; Harilal S; Batiha GE; Cruz-Martins N; Magdy O; Musa A; Panda DS; Mathew B
    Mol Neurobiol; 2022 Jan; 59(1):191-233. PubMed ID: 34655056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
    Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Veres G; Schmidt M; Kutschera I; Vidaud M; Abel U; Dal-Cortivo L; Caccavelli L; Mahlaoui N; Kiermer V; Mittelstaedt D; Bellesme C; Lahlou N; Lefrère F; Blanche S; Audit M; Payen E; Leboulch P; l'Homme B; Bougnères P; Von Kalle C; Fischer A; Cavazzana-Calvo M; Aubourg P
    Science; 2009 Nov; 326(5954):818-23. PubMed ID: 19892975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.
    Benhamida S; Pflumio F; Dubart-Kupperschmitt A; Zhao-Emonet JC; Cavazzana-Calvo M; Rocchiccioli F; Fichelson S; Aubourg P; Charneau P; Cartier N
    Mol Ther; 2003 Mar; 7(3):317-24. PubMed ID: 12668127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions.
    Uchitel J; Kantor B; Smith EC; Mikati MA
    Pediatr Neurol; 2020 Sep; 110():5-19. PubMed ID: 32684374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
    Donde A; Wong PC; Chen LL
    Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.
    Cartier N; Aubourg P
    Brain Pathol; 2010 Jul; 20(4):857-62. PubMed ID: 20626747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection.
    Salgar SK; Yang D; Ruiz P; Miller J; Tzakis AG
    Hum Gene Ther; 2004 Feb; 15(2):131-44. PubMed ID: 14975186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplant outcomes in leukodystrophies.
    Orchard PJ; Tolar J
    Semin Hematol; 2010 Jan; 47(1):70-8. PubMed ID: 20109614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy in spinal muscular atrophy.
    Audic F
    Arch Pediatr; 2023 Nov; 30(8S1):8S12-8S17. PubMed ID: 38043977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-based therapies for neurodegenerative diseases.
    Sun J; Roy S
    Nat Neurosci; 2021 Mar; 24(3):297-311. PubMed ID: 33526943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
    Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
    Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy.
    Al-Saady M; Beerepoot S; Plug BC; Breur M; Galabova H; Pouwels PJW; Boelens JJ; Lindemans C; van Hasselt PM; Matzner U; Vanderver A; Bugiani M; van der Knaap MS; Wolf NI
    Ann Clin Transl Neurol; 2023 Jul; 10(7):1146-1159. PubMed ID: 37212343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy.
    Bergner CG; van der Meer F; Winkler A; Wrzos C; Türkmen M; Valizada E; Fitzner D; Hametner S; Hartmann C; Pfeifenbring S; Stoltenburg-Didinger G; Brück W; Nessler S; Stadelmann C
    Glia; 2019 Jun; 67(6):1196-1209. PubMed ID: 30980503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease.
    Sergijenko A; Langford-Smith A; Liao AY; Pickford CE; McDermott J; Nowinski G; Langford-Smith KJ; Merry CL; Jones SA; Wraith JE; Wynn RF; Wilkinson FL; Bigger BW
    Mol Ther; 2013 Oct; 21(10):1938-49. PubMed ID: 23748415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.